Primax Medica sp. z o.o.
Ul. Ludwika Solskiego 14, 62-040 Puszczykowo
TAX ID7810025001
Phone+48 61 668 20 20
Rate company:
Primax Medica sp. z o.o.
TAX ID7810025001
KRS0000942723
Share capital123,243.00 zł
Not confirmed
No opinion.   Add your first review

address

Ul. Ludwika Solskiego 14, 62-040 Puszczykowo

Phone number

+48 61 668 20 20

About us

This text has been translated automatically

We are a producer and official distributor of medical devices for the treatment of pain in the spine and joints. The products manufactured by our company produce a permanent magnetic field with the use of the innovative technology of MULTIGRADENT Magnetic Systems MMSTherapyTM - developed at the Institute of Physical-medical Research, which is a research and development part of our company.

The Institute has been operating since 1995, and its Scientific Council consists of prominent specialists from leading scientific and clinical centers. The Institute is a leader among scientific institutions dealing with the application of physical medicine in home therapy. Over the last 20 years, it has developed unique therapeutic methods that have already benefited over 100,000 people. Information on the Institute's activities can be found at www.ibf.com.pl as well as on Wikipedia and the Nauka Polska portal.

The goal of Primax Medica Sp. z o. o. meets the needs and meets the expectations of clients by providing them with medical devices in accordance with their expectations and the requirements of the Directive for medical devices 93/42 / EEC Annex II and EN ISO 13485: 2016 and EN ISO 13485: 2016 / AC: 2016 - and all this in compliance with the law and based on high ethical standards. We strive to be the leader in the field of offered medical devices on the Polish market. We gain competitive advantage through the use of new technologies and professional and professional service for all customers. In order to achieve full customer satisfaction, we conduct continuous market observation, train the crew, modernize technical infrastructure and cooperate with renowned entities with global reach. We invest in new technologies, systematically improving the quality of our medical products.

The DirectMagnetic brand is a series of magnetic products made of high quality components that provide aesthetic and functional qualities and are:

EFFECTIVE AND SAFE

In our products we have used modern technology of MMS THERAPY multigradient magnetic systems, which guarantees their effectiveness and safety.

CONSTRUCTED BY SPECIALISTS

Our products are the result of the work of specialists from the Institute of Physical Research from Puszczykowo, who have over 20 years of experience in the field of solid magnetic field therapy.

MEDICAL COMPONENT

The products of the DIRECTMAGNETIC series are Class I medical devices for which we have performed a full clinical evaluation and safety analysis.

INDICATIONS

Musculoskeletal, rheumatic and post-traumatic pain.

We operate based on a sales distribution network, which we develop all the time, and also conduct direct sales based on the e-commerce channel. Our products can be successfully ordered directly on the company's website and in extensive sales points cooperating with our company.

Offer

This text has been translated automatically

ladies and gentlemen

We invite you to cooperate in the distribution of DirectMagnetic medical products, intended for the treatment of pain in the spine and joints. The products manufactured by our company produce a permanent magnetic field with the use of the innovative technology of MULTIGRADENT Magnetic Systems MMSTherapyTM - developed at the Institute of Physical-medical Research, which is a research and development part of our company.

The Institute has been operating since 1995, and its Scientific Council consists of prominent specialists from leading scientific and clinical centers. The Institute is a leader among scientific institutions dealing with the application of physical medicine in home therapy. Over the last 20 years, it has developed unique therapeutic methods that have already benefited over 100,000 people. Information on the activities can be found on the Institute's website at, and in, and on the portal.

We want to offer you a proven cooperation model based on B2B business channel with logistics support on the basis of dropshipping or cross-docking. The proposed model is a great solution that provides you with a trouble-free availability of our products, without the need to involve additional resources and create inventory. As part of the cooperation, we provide you with access to on-line warehouse resources, product photos and specialist descriptions of the products offered, company catalogs and a full range of product knowledge. For business entities with extensive sales infrastructure in the e-commerce model, we provide ready-made tools that integrate the offer.

Distribution of our products is not only an opportunity to expand your range, but also to provide your customers with high quality, effective and safe medical devices manufactured in Poland.

Activity type

manufacturer

Register Data

Full name

SATROECG SPÓŁKA AKCYJNA

Copy
uses securityreCAPTCHA

Legal address

UL. MACIEJA PALACZA 144, 60-278 POZNAŃ

NIP

7810025001
Copy

REGON

630543106
Copy

KRS

0000942723
Copy

Legal form

joint stock company

ALEO.com Registration Date

2018-12-04

Register Address

UL. MACIEJA PALACZA 144, 60-278 POZNAŃ

Date of registration in KRS

2021-12-30

Date of commencement of economic activity

2021-12-30

Act signature

RDF/676556/24/532

Pkd codes

86.90.E - Other human health activities notelsewhere classified

22.29.Z - Manufacture of other plastic products

32.99.Z - Other manufacturing notelsewhere classified

46.46.Z - Wholesale of pharmaceutical goods

47.19.Z - Other retail sale in non-specialised stores

47.99.Z - Other retail sale not in stores, stalls or markets

62.01.Z - Computer programming activities

64.19.Z - Other monetary intermediation

64.99.Z - Other financial service activities, except insurance and pension funding not elsewhere classified

72.19.Z - Other research and experimental development on natural sciences and engineering


Active
Vat list bank account(s)

Company authorities

representation authorityMANAGEMENT
supervisory authorityboard of directors
representation type
DO SKŁADANIA OŚWIADCZEŃ WOLI I PODPISYWANIA W IMIENIU SPÓŁKI UPOWAŻNIENI SĄ: - W PRZYPADKU ZARZĄDU JEDNOOSOBOWEGO – PREZES ZARZĄDU SAMODZIELNIE, - W PRZYPADKU ZARZĄDU WIELOOSOBOWEGO – DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE ALBO JEDEN CZŁONEK ZARZĄDU ŁĄCZNIE Z PROKURENTEM.
MANAGEMENT
Tomasz Wołynko
Member Of The Board, 51 years old
Łukasz Jerzy Janicki
Member Of The Board, 41 years old
BOARD OF DIRECTORS
Paweł Stanisław Magdziarz
39 years old
Łukasz Jerzy Szyło
51 years old
Marek Adam Turcza
43 years old
Maciej Józef Duda
51 years old
Michał Janicki
38 years old

Financial data

Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
2021 2022 2023
M PLN
M PLN
M PLN
%
Gross profit (loss) Indicator description
-0,8
-0,4
-0,5
-27
EBITDA Indicator description
-0,8
-0,3
-0,4
-21,9
Short time liabilities Indicator description
0
1,2
1,2
0,4
Equity capital Indicator description
0,1
-0,4
-0,3
16,2
Operating profit (EBIT) Indicator description
-0,8
-0,4
-0,4
-21,3
Assets Indicator description
0,8
0,8
0,9
8,2
Net profit (loss) Indicator description
-0,8
-0,4
-0,5
-27
Cash Indicator description
0
0
0
58,4
Net income from sale Indicator description
0,4
0
0
710,8
Liabilities and provisions for liabilities Indicator description
0,8
1,2
1,2
0,7
Working assets Indicator description
0,1
0,1
0,1
15,1
Depreciation Indicator description
0
0
0
0
%
%
%
p.p.
Profitability of capital Indicator description
-1069,5
121,3
183,8
62,5
Equity capital to total assets Indicator description
9
-44,2
-34,3
9,9
Gross profit margin Indicator description
-210,9
-78 087
-12 227,9
65 859,1
EBITDA Margin Indicator description
-201,4
-62 548,7
-9408,5
53 140,2
Days
Days
Days
Days
Short term commitment turnover cycle Indicator description
0
766 227
94 851
-671 376
Current financial liquidity indicator Indicator description
0.07473061978816986
0.08543774485588074
0
Net dept to EBITDA Indicator description
-0.8017511367797852
-3.247236967086792
-2.666820764541626
0,5
See more

Financial statements

01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf

01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf

01-01-2023 - 31-12-2023
Activity report
Download pdf
Show more (3)
uses security  reCAPTCHA

Opinions

Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane

0/ 5.0
How do you rate this company?
Your opinion matters to us.

Companies registered in the same sector